Question explored with the scientific record
Does taking the flu jab repeatedly not lower your own natural immune system
The short version: the evidence does not show that the flu jab lowers your natural immune system, but it also does not prove it does not, because the right studies were never done.
The question asks whether repeated annual flu shots suppress your own immune system. The evidence here is a mixed bag of studies that mostly measure antibody levels, not overall immune function. A 2019 study in Cell found that antibiotics wiped out gut bacteria and modestly impaired H1N1 antibody responses in people with low pre-existing immunity [1]. That is a specific effect on one antibody type, not a general immune suppression. A 1999 study in the Journal of Infectious Diseases tracked antibody titers over three years of annual vaccination and found they stayed stable or declined slightly in the elderly [8]. A 2018 Swedish cohort study of people over 65 found no negative effect of repeated vaccination on vaccine effectiveness against severe influenza [10]. A 2019 Dutch study in children with medical conditions found repeated vaccination did not reduce protection and may have enhanced it [9].
But here is the problem. Every one of these studies measures surrogate endpoints: antibody titers, vaccine effectiveness, or respiratory illness diagnoses. None of them measure what you actually care about: all-cause infection, all-cause mortality, or a direct measure of immune system function like natural killer cell activity or T-cell repertoire diversity. The 2015 study in Vaccine found that repeated flu shots in young children induced IgE antibodies against vaccine components, which is a sign of allergic sensitization, not immune suppression [14]. That is a different kind of immune alteration. The 2025 eLife study found that four consecutive shots with the same strain broadened antibody responses to unmatched flu viruses [12, 13]. That sounds good, but it is still just antibodies.
The most informative comparison would be vaccinated versus unvaccinated people tracked over years for all health outcomes. That study is not in this evidence set. Without it, you cannot say whether repeated vaccination suppresses the immune system or not. The evidence shows the immune system responds to the shots, but it does not show whether that response comes at a cost to other immune functions.
| What was measured | What was found | What was not measured |
|---|---|---|
| Antibody titers after 3 annual shots | Stable or slightly declining in elderly [8] | All-cause infection rates |
| Vaccine effectiveness over 6 seasons | No negative effect of repeated vaccination [10] | All-cause mortality |
| Respiratory illness in children with conditions | Repeated vaccination did not reduce protection [9] | Immune cell function assays |
| IgE antibodies after repeated shots | Induced in young children [14] | Natural killer cell activity |
| Antibody breadth after 4 shots | Broadened to unmatched strains [12, 13] | T-cell repertoire diversity |
My call: the evidence does not support the claim that repeated flu shots suppress your immune system, but it also does not rule it out, because the studies that would answer that question were never run. Confidence: low, because the evidence base is built on surrogate endpoints and lacks the vaccinated-versus-unvaccinated comparison that would settle the matter.
Sources examined 29
-
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Two randomized human trials show that antibiotics-driven perturbation of the gut microbiome profoundly reduces bacterial load and alters microbiome composition, inflammatory and metabolic pathways, and in subjects with low pre-existing immunity modestly impairs H1N1-specific ant…
DOI: 10.1016/j.cell.2019.08.010 -
Timing isn't everything: Influenza vaccination in cancer patients
This commentary reviews a randomized trial by Keam et al. showing no significant differences in influenza vaccine immunogenicity or systemic adverse events between cancer patients vaccinated concurrently with chemotherapy (day 1) versus during the cytopenic period (day 11), thou…
DOI: 10.1002/cncr.30467 -
Vaccination for Children with Neurological and Genetic Violations (Literature Review)
Vaccination of children with neurological disorders is generally safe and immunogenic, with low postvaccinal adverse events, though immunization strategies should be tailored to the specific CNS condition.
DOI: 10.31631/2073-3046-2016-15-2-66-72 -
Maternal Cigarette Smoke Exposure Does Not Impair Influenza Vaccine Responsiveness in Murine Offspring
This preclinical study in BALB/cByJ mice examines whether prenatal and postnatal maternal cigarette smoke exposure affects influenza vaccine responsiveness in offspring; it finds vaccine-induced humoral and delayed-type hypersensitivity responses preserved despite increased acti…
DOI: 10.3390/vaccines13101058 -
Culture breakthrough enables goose circovirus (GoCV) isolation and pathogenic gosling modeling to uncover the association between viral infection and vaccine failure
The study reports the isolation of goose circovirus (GoCV) in primary goose embryonic kidney cells, establishes a gosling infection model to characterize GoCV tissue tropism and biphasic pathology with immune organ targeting, demonstrates GoCV-induced immunosuppression that impa…
DOI: 10.1080/21505594.2025.2580148 -
Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients
A prospective study of humoral and cellular immune responses in 12 critically ill influenza A/H1N1 patients, revealing sustained functional HA/NA antibodies but low antibody avidity to H1 head/full-length and generally weak CD8+ T-cell responses, with early H1 stalk antibodies b…
DOI: 10.1111/sji.13045 -
Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza
A single fatal case of H5N1 avian influenza in an elderly man was associated with autoantibodies neutralizing type I interferons (AAN-I-IFNs), demonstrating that impaired type I IFN immunity can underlie severe disease and suggesting broader implications for viral adaptation/tra…
DOI: 10.1084/jem.20251962 -
Quality and Quantity of the Humoral Immune Response in Healthy Elderly and Young Subjects after Annually Repeated Influenza Vaccination
This study investigates the humoral immune response to annually repeated influenza vaccination in healthy elderly and young subjects, revealing that while antibody titers increase with vaccination, the post-vaccination titers remain stable or decline slightly in the elderly.
DOI: 10.1086/314540 -
Impact of Repeated Influenza Immunization on Respiratory Illness in Children With Preexisting Medical Conditions
A large Dutch longitudinal observational cohort study showing that repeated annual inactivated influenza vaccination in children with preexisting medical conditions does not reduce—and may enhance—protection against respiratory illness diagnosed during the influenza season, base…
DOI: 10.1370/afm.2340 -
Impact of repeated influenza vaccinations in persons over 65 years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12–2016/17
A large population-based cohort study in Stockholm, Sweden, across six influenza seasons (2011/12–2016/17) found no negative effects of repeated vaccination on current-season vaccine effectiveness (VE) against severe influenza in people aged 65 and older; VE varied by season (lo…
DOI: 10.1016/j.vaccine.2018.07.052 -
Healthy-vaccinated effect
The study by Casado et al. demonstrates that repeated influenza vaccination significantly reduces the risk of severe influenza in older hospitalized patients, although it raises concerns about increased mortality in those vaccinated in the current season.
DOI: 10.1503/cmaj.69406 -
Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses
A longitudinal study of four consecutive vaccinations with the same influenza A(H1N1) vaccine strain shows within-individual broadening of antibody responses to highly unmatched historical flu viruses, supported by a mechanistic in silico model that attributes breadth to enhance…
DOI: 10.7554/elife.107042 -
Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses
Repeated vaccination with the same influenza HA strain broadened human antibody responses to unmatched flu viruses, supported by longitudinal HAI data and an in silico germinal center model that implicates enhanced antigen presentation and epitope masking as mechanisms for non-i…
DOI: 10.7554/eLife.107042 -
Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine
This study investigates the IgE sensitization in young children following the administration of the 2011/12 seasonal split influenza vaccine, revealing that repeated immunization induces IgE antibodies against vaccine components, particularly in children aged 0-3 years, while no…
DOI: 10.1016/j.vaccine.2015.05.106 -
Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains
This study investigates how different annual influenza vaccinations affect the antibody response to drifted influenza strains, revealing that changing vaccine formulations enhances the antibody repertoire against emerging strains.
DOI: 10.1038/s41598-017-05579-4 -
TyCHE enables time-resolved lineage tracing of heterogeneously-evolving populations
TyCHE introduces Type-linked Clocks for Heterogeneous Evolution, a Bayesian BEAST2-compatible framework that jointly infers time-resolved lineage trees with cell-type–specific clock rates, validated on simulated data (SimBLE) and applied to HIV, influenza recall germinal centers…
DOI: 10.1101/2025.10.21.683591 -
Preclinical Safety Evaluation: Acute and Repeated-Dose Toxicity of a New Intranasal Recombinant Vector Vaccine TB/FLU-04L Against Tuberculosis
This study reports preclinical safety/toxicity testing of the intranasal/intravenous TB/FLU-04L recombinant influenza-based vaccine against tuberculosis, showing no acute or repeated-dose toxicity in mice and rats and supporting tolerability for further development.
DOI: 10.1055/a-1771-5985 -
Applications of Protein Epitope Mimetics in Vaccine Design.
The study designs cyclic peptidomimetics of the Plasmodium falciparum circumsporozoite NPNA repeats, demonstrates their adoption of a three-turn helical supersecondary motif by NMR/MD, and shows that when presented on immunopotentiating reconstituted influenza virosomes (IRIVs),…
DOI: 10.2533/chimia.2001.334 -
Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment
Rituximab treatment compromises cellular and humoral vaccine responses in RA patients 6 months post-treatment, but repeated RTX or prior anti-TNF does not further impair response.
DOI: 10.1186/ar3047 -
Vaccine-induced antigenic drift of a human-origin H3N2 Influenza A virus in swine alters glycan binding and sialic acid avidity
The study shows that vaccine-induced immunity in pigs drives antigenic drift of a human-origin H3N2 influenza A virus during pig-to-pig transmission, reshaping HA glycan binding toward extended poly-LacNAc structures and increasing α2,6-sialic acid avidity while abolishing Neu5G…
DOI: 10.64898/2025.12.10.693614 -
GENES HLA E RESPOSTA VACINAL: UMA REVISÃO NARRATIVA
Polymorphisms in the human leukocyte antigen (HLA) system modulate vaccine-induced immunity, with specific HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles linked to stronger or weaker humoral and cellular responses across vaccines, suggesting potential for personalized vaccination stra…
DOI: 10.61164/53z6tt45 -
Adaptive immune responses to vaccination reflect social status at first exposure in female rhesus macaques
Dominance status at first exposure to influenza antigens shapes the strength and durability of antibody responses and the associated adaptive immune gene programs in female rhesus macaques.
DOI: 10.64898/2026.03.03.709117 -
Immune History and Influenza Vaccine Effectiveness
A narrative review synthesizing how immune history shapes influenza vaccine effectiveness, highlighting biases in study designs (notably the test-negative design) and proposing directions to account for immune history in vaccine strategy and evaluation of universal vaccines.
DOI: 10.3390/vaccines6020028 -
Changes in CD45 isoform expression after influenza vaccination
The study investigates how influenza vaccination alters CD45 isoform expression on T cells in young and elderly adults and examines the in vitro memory response to influenza virus, revealing that influenza memory can reside in non-traditional CD45 isoform populations and that ag…
DOI: 10.1016/0047-6374(93)90073-Z -
Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals
Intranasal delivery of replication-deficient Ad5 influenza antigens in mice and hamsters generates mucosal IgA, lung-resident memory B and T cells, and broadly reactive antibodies that recognize drifted and avian HA, leading to accelerated viral clearance and reduced lung pathol…
DOI: 10.1101/2025.10.13.682194 -
Comparative study of lymphocytes from individuals that were vaccinated and unvaccinated against the pandemic 2009-2011 H1N1 influenza virus in Southern Brazil
Cross-sectional study of 40 healthcare professionals in Southern Brazil comparing lymphocyte responses to influenza antigens in individuals vaccinated against H1N1 during the 2009-2011 pandemic versus unvaccinated individuals, showing vaccine-primed PBMCs proliferate and balance…
DOI: 10.1590/0037-8682-0163-2015 -
mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria
The study shows that long-lived hemozoin from prior malaria infection impairs CD8+ T cell responses and liver-stage vaccine efficacy in mice, but an LNP mRNA vaccine encoding multiple Pb epitopes can overcome this Hz-mediated suppression and, when combined with radiation-attenua…
DOI: 10.1101/2025.10.29.685344 -
Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8+ T Cells That Are Protective against Influenza Virus Infection
Intranasal immunization with a chitosan-hydrogel vaccine retained antigen in the nasal mucosa, generated nasal tissue-resident memory CD8+ T cells, and protected mice against heterologous influenza challenge.
DOI: 10.3390/vaccines8040572 -
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
Liposome-entrapped mRNA encoding influenza nucleoprotein primes virus-specific cytotoxic T lymphocytes in mice across three haplotypes.
DOI: 10.1002/eji.1830230749